Barclays raised the firm’s price target on Boston Scientific (BSX) to $136 from $133 and keeps an Overweight rating on the shares. The company issued an “impressive” three-year plan with organic ...
With valuations of crypto treasury companies headed very quickly south in recent weeks, sector consolidation seemed a certainty at some point, with the only question being when it would start. Strive ...